04 Jun 2024

Biomanufacturing policy summit report 2024: policy pathways for biomanufacturing in Europe

This report summarises the summit’s main discussion points and takeaways and uses them as a foundation to build a strengths, weaknesses, opportunities and threats (SWOT) analysis for biomanufacturing in Europe.

The Biomanufacturing Policy Summit is an annual meeting organised by EuropaBio that brings together biotech industry representatives and policymakers to discuss the most timely and relevant topics for biomanufacturing across sectors. The 2024 edition occurred in Brussels on 13th March and gathered 73 participants, including participants from the European Commission and the European Parliament.

“Policy pathways for biomanufacturing in Europe” was the Summit theme and the umbrella topic for discussions on the best ways to defragment and accelerate biomanufacturing in the EU, plus biomanufacturing policies from other global regions. It is a critical timing for biomanufacturing, as different policy files are underway at the EU level, with an impact on relevant products or processes including biopharmaceuticals, new genomic techniques, detergents, alternative proteins and cell cultivation.

This report summarises the Summit’s main discussion points and takeaways and uses them as a foundation to build a Strengths, Weaknesses, Opportunities and Threats (SWOT) analysis for biomanufacturing in Europe. The analysis is further refined with data from recent reports and examples provided by EuropaBio's members, in order to add evidence and practical examples to support the arguments. Following the 2023 report which presented 10 recommendations for biomanufacturing, the 2024 SWOT analysis aims to act as an open conclusion from the Summit, adding substance to the ongoing debate around biomanufacturing in Europe.

The report stresses the urgent need to address the question “What does the EU want to be?” and build an answer with pillars in innovation, skills, smart and agile legislation and financial instruments, and the Single Market. The EU needs a smart industrial policy for biotech and biomanufacturing rooted in science-based policymaking, which promotes and incentivises the scale-up of infrastructures and sustainable solutions and creates innovative and resilient supply chains, whilst answering the EU’s long-term ambitions.

 

Related topics

×
deep biotech.png

Welcome to the new BIA site!

BIA are excited to announce the soft launch of our new website!

Our team is diligently working behind the scenes to enhance your browsing experience and provide you with valuable content. During this phase, you may encounter sections that are still under construction. We kindly ask for your patience as we finalise everything.

Thank you for visiting, and we thank you for your continuous support towards BIA.